| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 7,097,190 | 7,213,335 |
| Effect of foreign currency translation on cash | 18,301 | 5,631 |
| Net change in cash, cash equivalents, and restricted cash | -2,699,177 | 294,323 |
| Cash and cash equivalents at beginning of period | 6,922,729 | - |
| Cash and cash equivalents at end of period | 4,223,552 | - |
Pasithea Therapeutics Corp. (KTTA)
Pasithea Therapeutics Corp. (KTTA)